Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Omnia Biologics, Inc.
Omnia Biologics Expands on Drug Development Cost-Management Services
April 22nd, 2009
Omnia Biologics, Inc. announced that the Company is further strengthening its service offerings by expanding process development capabilities for companies undertaking cost-cutting measures to preserve capital. “Omnia understands that much of the overhead associated with drug development requires the application of assets having high fixed and overhead costs,” said Dale VanderPutten, Ph.D., Chief Executive Officer of Omnia. “We have built our business model recognizing these costs are a strain for many firms. Outsourcing non-core activities reduces the risk drug developers face while allowing them to manage cash, contain costs, focus on core strengths, maintain...
Source: Vaccine Weekly (2009-04-22)
|
